<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
March 31, 1997
-------------------------------------------------
(Date of Report; Date of Earliest Event Reported)
Sepracor Inc.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware
----------------------------------------------
(State or other jurisdiction of incorporation)
0-19410 22-2536587
- ------------------------ ----------------
(Commission File Number) (I.R.S. Employer
Identification No.)
111 Locke Drive, Marlborough, Massachusetts 01757
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(508) 481-6700
- --------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
<PAGE> 2
INFORMATION TO BE INCLUDED IN THE REPORT
ITEM 5. OTHER EVENTS
On March 31, 1997, Sepracor Inc. ("Sepracor") sold all of its shares of
common stock of Chirex Inc., a Delaware corporation, in an underwritten public
offering, resulting in net proceeds to Sepracor of approximately $31,125,000
(after payment of underwriting discounts and commissions but before payment of
the other expenses associated with the offering).
-2-
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: April 4, 1997 SEPRACOR INC.
By: /s/ Robert F. Scumaci
--------------------------
Robert F. Scumaci
Senior Vice President,
Finance and Administration
-3-
